Offshore Contracts and Liabilities
... Markerstudy Insurance Co. Ltd v . Endsleigh Insurance Services Ltd , 80 one of the clauses under consideration81 was : Endsleigh will not be liable to Markerstudy for any indirect or consequential loss or loss of profit or loss of ...
Disadvantage Marker Study
... Marker Study - Stage One : Adviser Workshop Overall research aim for the workshop : To construct a ' profile ' or typology of disadvantaged Jobcentre customers Specifically , it aims to gather : Contextual information regarding ...
Medicare Program
... MARKER STUDY 0.00 0.08 0.01 0.09 XXX 88180 26 CELL MARKER STUDY 0.19 0.18 0.01 0.38 2 XXX 88182 CELL MARKER STUDY 0.81 0.70 0.05 1.56 2 XXX 88182 TC CELL MARKER STUDY 0.00 0.23 0.02 0.25 XXX 88182 26 CELL MARKER STUDY 0.81 0.47 0.03 ...
Federal Register
... marker study 0.36 NA 0.67 0.03 NA 1.06 XXX 88180 26 A Cell marker study 0.36 0.16 0.16 0.01 0.53 0.53 XXX 88180 TC A Cell marker study 0.00 NA 0.51 0.02 NA 0.53 XXX 88182 A Cell marker study 0.77 NA 1.74 0.06 NA 2.57 XXX 88182 26 A ...
OWCP Medical Fee Schedule 1999
... marker study 88180 TC 0.00 Cell marker study 88180 26 0.36 Cell marker study 88182 70 0.77 Cell marker study 88182 TC 0.00 Cell marker study 88182 26 0.77 Cell marker study 88199 70 0.00 Cytopathology procedure CPT MODI MOD WORK CODE ...
Louisiana Register
... marker study Cytopathology , fluids Cell marker study Cytopathology , fluids Cell marker study Cytopathology , fluids Cell marker study Cytopathology , fluids Cell marker study Cytopathology , fluids Cell marker study Cytopathology ...
Medicare RBRVS
... marker study 0.36 0.60 0.60 0.03 0.99 $ 35.84 0.99 $ 35.84 XXX 88180-26 Cell marker study 0.36 0.17 0.17 0.01 0.54 $ 19.55 0.54 $ 19.55 XXX 88180 - TC Cell marker study 0.00 0.43 0.43 0.02 0.45 $ 16.29 0.45 $ 16.29 XXX 88182 Cell ...
Adult T Cell Leukemia and Related Diseases
... marker study . A family study was performed on all these non - Hodgkin lymphoma cases . Of the 13 families with familial disposition , 3 having sibling cases are presented since satisfactory data on their clinicopathological features is ...
Red-light Running and Limited Visibility Due to LTV's Using the UCF Driving Simulator
... Marker Study Yellow Onset 82.0 110. 138. 166. 194 . 222 . Distance 0 11 23 34 46 57 Cross Count 41 40 36 22 3 1 % within 97.6 95.2 85.7 52.4 7.1 % 2.4 % Distance % % % % Stop Count 1 2 6 20 % within Distance 2.4 % 4.8 % 14.3 % 47.6 39 ...
AIDS Therapy
... marker study CNAB3002 : treatment- experienced surrogate marker study CNAB3005 : treatment - naive surrogate marker study CNAA3006 : treatment- experienced surrogate marker study AIDS Dementia CNAAB3001 : HIV - 1 AIDS dementia ...
State Register
... marker study 0.55 0.55 XXX 0 0 0 0 88182 A Cell marker study 1.33 1.33 XXX 0 0 0 0 0 88300 A Surgical pathology 0.23 0.23 XXX 0 0 0 0 0 88302 A Tissue examination 0.44 0.44 XXX 0 0 0 0 0 88304 A Tissue examination 0.64 0.64 XXX 0 0 0 0 ...
ACS Surgery
... marker study is more widely available . For the radiopaque marker study , 20 radiopaque markers ( prepackaged in gelatin capsules ) are ingest- ed , and an abdominal x - ray ( which includes the pelvis ) is taken on day 5. The ...
Physicians Fee & Coding Guide
... marker study [ A ] 0.77 1.97 * 1.97 0.07 88182 TC Cell marker study [ A ] 0.00 1.69 * 1.69 0.04 88182 26 Cell marker study [ A ] 0.77 0.28 0.28 0.03 88184 Flowcytometry / tc , 1 marker [ A ] 0.00 1.60 * 1.60 0.02 88185 Flowcytometry ...
Diseases of the Hematopoietic System
... marker study reveals a viability level of 80 % . This is the lowest limit to which we will accept the validity of a marker study . There is latex ingestion of 44 % , which is quite elevated . Note that there is a virtual absence of T ...
Wakayama Medical Reports
... MARKER STUDY Peripheral blood mononuclear cells iso- lated by Ficoll - Paque density gradient centrifugation and the tumor cells ob- tained as described above were adopted with minor modification for lymphocyte surface marker study ...
The Journal of Lending & Credit Risk Management
... Marker Study 97 % 65 % 50 % Per Asarnow & Marker Study 2 2 2 6 6 6 18 18 18 106 106 106 520 520 520 1979 1979 1979 1 1 0.10 % 0.10 % 0.10 % 0.33 0.33 na 50 % of default prob R2 Obligor - Specific Risk Constant Correlation Factor ...
Genetic Variability in the Slender Wild Oat Avena Barbata in California
Raymond Dale Miller. IV - B . Seed Marker Study This section will report the results of the seed marker study , the first study of three to learn more about genetic variability in the species . The collections reported in Table III - A ...
Atlas of Cytochemistry & Immunochemistry of Hematologic Neoplasms
... marker study using E - rosetting and an immunofluorescence technique revealed 9 % phagocytic cells , 36 % T - cells , and 48 % B - cells . Twelve percent of the cells were positive for IgG , 9 % for IgA , 27 % for IgM , 5 % for IgD , 45 ...
Physicians' Medicare Fee Schedule
... marker study 0.36 0.33 0.03 0.72 XXX N 88180 26 A Cell marker study 0.36 0.17 0.01 0.54 XXX N 88180 TC A Cell marker study 0.00 0.16 0.02 0.18 XXX N 88182 A Celt marker study 0.77 0.89 0.07 1.73 XXX N 88182 26 A Cell marker study ...
Journal of the National Cancer Institute
... marker study is much easier to conduct than a randomized clinical trial . Often , institutional review requirements are minimal and formal protocols are rare ; data collection may be informal and not stringently quality con- trolled ...